Tecfidera Prices, Coupons, Copay Cards & Patient Assistance
Tecfidera (dimethyl fumarate) is a member of the selective immunosuppressants drug class and is commonly used for Multiple Sclerosis.
The cost for Tecfidera 120 mg oral delayed release capsule is around $2,330 for a supply of 14 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Tecfidera is available. See dimethyl fumarate prices (from $165.76 for 14 capsules).
Tecfidera prices
Oral Delayed Release Capsule
120 mg
Tecfidera oral delayed release capsule
from $2,330.16
for 14 capsules
Quantity | Per unit | Price |
---|---|---|
14 | $166.44 | $2,330.16 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
240 mg
Tecfidera oral delayed release capsule
from $9,954.94
for 60 capsules
Quantity | Per unit | Price |
---|---|---|
60 | $165.92 | $9,954.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Tecfidera Coupons, Copay Cards and Rebates
Tecfidera offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tecfidera Biogen Copay Program
Eligible commercially insured patients may have their medication cost lowered to as little as $0.
- Applies to:
- Tecfidera
- Number of uses:
- per prescription per year
Form more information phone: 800-456-2255 or Visit website
Patient Assistance & Copay Programs for Tecfidera
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Tecfidera (dimethyl fumarate) Capsule; Delayed Release
More information please phone: 866-316-7263 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Tecfidera (dimethyl fumarate)
- Check interactions
- Compare alternatives
- Reviews (98)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español